|  Help  |  About  |  Contact Us

Publication : LUBAC prevents lethal dermatitis by inhibiting cell death induced by TNF, TRAIL and CD95L.

First Author  Taraborrelli L Year  2018
Journal  Nat Commun Volume  9
Issue  1 Pages  3910
PubMed ID  30254289 Mgi Jnum  J:267737
Mgi Id  MGI:6268256 Doi  10.1038/s41467-018-06155-8
Citation  Taraborrelli L, et al. (2018) LUBAC prevents lethal dermatitis by inhibiting cell death induced by TNF, TRAIL and CD95L. Nat Commun 9(1):3910
abstractText  The linear ubiquitin chain assembly complex (LUBAC), composed of HOIP, HOIL-1 and SHARPIN, is required for optimal TNF-mediated gene activation and to prevent cell death induced by TNF. Here, we demonstrate that keratinocyte-specific deletion of HOIP or HOIL-1 (E-KO) results in severe dermatitis causing postnatal lethality. We provide genetic and pharmacological evidence that the postnatal lethal dermatitis in Hoip(E-KO) and Hoil-1(E-KO) mice is caused by TNFR1-induced, caspase-8-mediated apoptosis that occurs independently of the kinase activity of RIPK1. In the absence of TNFR1, however, dermatitis develops in adulthood, triggered by RIPK1-kinase-activity-dependent apoptosis and necroptosis. Strikingly, TRAIL or CD95L can redundantly induce this disease-causing cell death, as combined loss of their respective receptors is required to prevent TNFR1-independent dermatitis. These findings may have implications for the treatment of patients with mutations that perturb linear ubiquitination and potentially also for patients with inflammation-associated disorders that are refractory to inhibition of TNF alone.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

29 Bio Entities

Trail: Publication

0 Expression